Ian Fotheringham

Dr. Ian Fotheringham received a Ph.D. in Molecular Biology from the University of Glasgow, UK, in 1986. With G. D. Searle pharmaceuticals, he engineered microbial production of human EGF, one of the first recombinantly produced biologics. At Monsanto Corp., Chicago, he successfully applied engineering biology and directed evolution for commercial manufacture of unnatural amino acids as chiral intermediates in the manufacture of HIV protease inhibitors. In 2003, Ian co-founded Ingenza and he has since led the organic growth of the company to become one of the world’s most versatile CRDMOs, accelerating the development of biologics, natural products and small molecule pharmaceuticals as well as bio-based products for many other industry sectors.